ahlam1399
09-26-2016, 03:48 PM
GW?s cannabis-derived drug succeeds in third epilepsy study
(Reuters) - Britain's GW Pharmaceuticals Plc said its experimental cannabis-derived drug for a rare form of childhood epilepsy succeeded in a third late-stage U.S. study.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=DJ7A9sDqBxs:BA1omfhuRko:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=DJ7A9sDqBxs:BA1omfhuRko:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=DJ7A9sDqBxs:BA1omfhuRko:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=DJ7A9sDqBxs:BA1omfhuRko:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=DJ7A9sDqBxs:BA1omfhuRko:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/DJ7A9sDqBxs
(Reuters) - Britain's GW Pharmaceuticals Plc said its experimental cannabis-derived drug for a rare form of childhood epilepsy succeeded in a third late-stage U.S. study.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=DJ7A9sDqBxs:BA1omfhuRko:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=DJ7A9sDqBxs:BA1omfhuRko:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=DJ7A9sDqBxs:BA1omfhuRko:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=DJ7A9sDqBxs:BA1omfhuRko:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=DJ7A9sDqBxs:BA1omfhuRko:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/DJ7A9sDqBxs